These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21781490)

  • 41. Synergistic interaction with arsenic trioxide and fractionated radiation in locally advanced murine tumor.
    Lew YS; Kolozsvary A; Brown SL; Kim JH
    Cancer Res; 2002 Aug; 62(15):4202-5. PubMed ID: 12154019
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improved tumor destruction with arsenic trioxide and radiofrequency ablation in three animal models.
    Hines-Peralta A; Sukhatme V; Regan M; Signoretti S; Liu ZJ; Goldberg SN
    Radiology; 2006 Jul; 240(1):82-9. PubMed ID: 16720872
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Opposite effects of arsenic trioxide on the Nrf2 pathway in oral squamous cell carcinoma in vitro and in vivo.
    Zhang X; Su Y; Zhang M; Sun Z
    Cancer Lett; 2012 May; 318(1):93-8. PubMed ID: 22155346
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effects of arsenic trioxide on the autoimmunity and survival time in BXSB lupus mice].
    Xia XR; Lin SX; Zhou Y
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Feb; 27(2):138-41. PubMed ID: 17345664
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of lymphoma growth in vivo by combined treatment with hydroxyethyl starch deferoxamine conjugate and IgG monoclonal antibodies against the transferrin receptor.
    Kemp JD; Cardillo T; Stewart BC; Kehrberg E; Weiner G; Hedlund B; Naumann PW
    Cancer Res; 1995 Sep; 55(17):3817-24. PubMed ID: 7641199
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of arsenic trioxide as an antivascular and thermosensitizing agent in solid tumors.
    Griffin RJ; Lee SH; Rood KL; Stewart MJ; Lyons JC; Lew YS; Park H; Song CW
    Neoplasia; 2000; 2(6):555-60. PubMed ID: 11228548
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Antitumor effect of BCG on growth of transplanted human myeloid leukemia HL-60 cells in nude mice].
    Wang YY; Wang LZ; Sun LR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):725-9. PubMed ID: 21729559
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In-vitro cytotoxic and genotoxic effects of arsenic trioxide on human leukemia (HL-60) cells using the MTT and alkaline single cell gel electrophoresis (Comet) assays.
    Yedjou CG; Tchounwou PB
    Mol Cell Biochem; 2007 Jul; 301(1-2):123-30. PubMed ID: 17216127
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The effect and mechanism of arsenic trioxide on hepatocellular carcinoma].
    Liu LX; Zhu AL; Chen W; Guo HX; Wang XQ; Liu ZH; Zhang TD; Jiang HC; Wu M
    Zhonghua Wai Ke Za Zhi; 2005 Jan; 43(1):33-6. PubMed ID: 15774171
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The mechanism of synergistic effects of arsenic trioxide and rapamycin in acute myeloid leukemia cell lines lacking typical t(15;17) translocation.
    Dembitz V; Lalic H; Ostojic A; Vrhovac R; Banfic H; Visnjic D
    Int J Hematol; 2015 Jul; 102(1):12-24. PubMed ID: 25758096
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting of EGFR increase anti-cancer effects of arsenic trioxide: Promising treatment for glioblastoma multiform.
    Mesbahi Y; Zekri A; Ahmadian S; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
    Eur J Pharmacol; 2018 Feb; 820():274-285. PubMed ID: 29274334
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effects of arsenic trioxide combined with cisplatin on the growth of human nasopharyngeal carcinoma cells and reversion of RASSF1A hympermethylation].
    Huang X; Wang X; Hu J; Zhou H; Zhang Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jul; 28(14):1061-5. PubMed ID: 25330645
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Arsenic trioxide induces apoptosis in uveal melanoma cells through the mitochondrial pathway.
    Chen MJ; Yang PY; Ye YZ; Hu DN; Chen MF
    Am J Chin Med; 2010; 38(6):1131-42. PubMed ID: 21061466
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Meta-analysis of all-trans retinoic acid-linked arsenic trioxide treatment for acute promyelocytic leukemia.
    Chen L; Wang J; Hu X; Xu X
    Hematology; 2014 Jun; 19(4):202-7. PubMed ID: 24074286
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Study on the inhibitory effect of small tripeptide CMS024 on tumor growth and metastasis in nude mice model of human hepatocellular carcinoma metastasis].
    Li Y; Tang ZY; Wang L; Yao Z; Lu R; Xue Q; Gao DM; Chen J
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(8):675-9. PubMed ID: 15130313
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intratumoral injection of arsenic to enhance antitumor efficacy in human esophageal carcinoma cell xenografts.
    Shen ZY; Zhang Y; Chen JY; Chen MH; Shen J; Luo WH; Zeng Y
    Oncol Rep; 2004 Jan; 11(1):155-9. PubMed ID: 14654919
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antitumor activity of arsenic trioxide on retinoblastoma: cell differentiation and apoptosis depending on arsenic trioxide concentration.
    Kim JH; Kim JH; Yu YS; Kim DH; Kim CJ; Kim KW
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1819-23. PubMed ID: 19060284
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Arsenic trioxide rewires mantle cell lymphoma response to bortezomib.
    Zhao LL; Liu YF; Peng LJ; Fei AM; Cui W; Miao SC; Hermine O; Gressin R; Khochbin S; Chen SJ; Wang J; Mi JQ
    Cancer Med; 2015 Nov; 4(11):1754-66. PubMed ID: 26310857
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transcriptomic analysis of the PI3K/Akt signaling pathway reveals the dual role of the c-Jun oncogene in cytotoxicity and the development of resistance in HL-60 leukemia cells in response to arsenic trioxide.
    Roszak J; Smok-Pieniążek A; Stępnik M
    Adv Clin Exp Med; 2017 Dec; 26(9):1335-1342. PubMed ID: 29442453
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Formulation Comprising Arsenic Trioxide and Dimercaprol Enhances Radiosensitivity of Pancreatic Cancer Xenografts.
    Tang R; Zhu J; Liu Y; Wu N; Han J
    Technol Cancer Res Treat; 2021; 20():15330338211036324. PubMed ID: 34433326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.